The prevalence of lymphoma in primary immunodeficiency cases and autoimmune
diseases, as well as on a background of immunodeficiency following organ transplants, is …

Background: An increased incidence of non-Hodgkin lymphoma (NHL) has been seen in
various primary immune deficiency (PID) cases. The present study aimed to evaluate the …

Abstract Background Non‐Hodgkin lymphomas (NHL) represent an important complication
of primary immunodeficiency (ID), posing new therapeutic challenges in this patient …

Children with primary immunodeficiency or chromosomal breakage syndromes are at
increased risk of developing non‐Hodgkin lymphomas; they cannot tolerate standard …

Introduction. Non‐Hodgkin lymphoma (NHL) is the most frequent malignancy associated
with primary immune deficiency disease (PID). We aimed to present the clinical …

Infusional CDE (cyclophosphamide, doxorubicin, etoposide; iCDE) is one of the most
effective chemotherapeutic regimen for human immunodeficiency virus (HlV)-associated …

Clinical data and biological samples were prospectively collected in 42 children with
lymphoproliferative disease (LPD) secondary to organ/bone marrow transplant‐related …

Lymphoproliferative disease (LPD) is a complication of congenital and acquired
immunodeficiency states. There are a number of treatment options for LPD arising after …

This objective of this study was to evaluate patients with immunodeficiency syndromes who
had developed malignant solid tumors and to examine survival rates and prognosis with …

The incidence of malignant lymphomas is significantly higher in patients who have
congenital or acquired immunodeficiencies. Although there are some differences between …